•  
  •  
  •  
  •  

2025-10-02 03:51:21

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  ChembondChemicals

Stock Report

  • Chembond Chemicals Ltd consolidated Q3FY25 profit lower at Rs. 11.71 crores
  • Chembond Chemicals Ltd Q1 FY25 consolidated net profit up QoQ at Rs. 7.96 crores
  • Chembond Chemicals Ltd posts consolidated PAT of Rs. 13.49 crores in Q3 FY2024
  • Chembond Chemicals Ltd posts consolidated PAT of Rs. 15.44 crores in Q2 FY2024
  • Chembond Chemicals Ltd posts consolidated PAT of Rs. 8.68 crores in Q1 FY24
  • Phiroze Sethna Pvt Ltd enters into deed of assignment for transfer of plant
  • Chembond Chemicals Ltd recommends dividend of Rs. 3
  • Chembond Chemicals Ltd Q4FY23 consolidated net profit rises to Rs. 10.20 crores
  • Chembond Chemicals Ltd reports consolidated PAT of Rs. 8.24 crores in Q3FY23
  • Chembond Chemicals Ltd Q2 FY2023 consolidated PAT rises to Rs. 7.61 crores
  • Chembond Chemicals Ltd reports consolidated loss of Rs. 1.36 crore in Q1FY23
  • Chembond Chemicals Ltd recommends dividend of Rs. 5
  • Chembond Chemicals Ltd consolidated Q4FY22 net profit drops to Rs. 2.08 crores
  • Fire incident at Chembond Chemicals Limited's Tarapur plant
  • Chembond Chemicals Q3FY22 consolidated PAT lower at Rs. 2.36 crore
  • Chembond Chemicals Ltd reports consolidated PAT of Rs. 4.68 crore in Q2FY22

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024